Indeed, anxiety and depressive disorder account for 40 % of reported disabilities worldwide. BioSystem Advancement is a privately kept company that develops and manufactures the AssayMAP Microchromatography platform to meet the analytical demands of the life sciences sector. Agilent announced the signing of an acquisition contract on Dec. 1. Financial information on the transaction weren’t disclosed. Related StoriesUnique, tiny proteins cage developed to deliver chemotherapy chemicals directly to tumor cellsUnderstanding how schizophrenia affects workings of the brainDiscovery could offer clues to how some infections control expression of genetic materialAs life science discovery and development continues to move toward a better understanding of biological responses to disease, and comes with an increased emphasis on protein-based therapeutics by pharmaceutical businesses, the necessity for automated, quality protein sample preparation and evaluation has become crucial.Martin O’Donnell, M.B., Ph.D., Andrew Mente, Ph.D., Sumathy Rangarajan, M.Sc., Matthew J. McQueen, M.B., Ph.D., Xingyu Wang, Ph.D., Lisheng Liu, M.D., Hou Yan, Ph.D., Shun Fu Lee, Ph.D., Prem Mony, M.D., Anitha Devanath, M.D., Annika Rosengren, M.D., Patricio Lopez-Jaramillo, M.D., Ph.D., Rafael Diaz, M.D., Alvaro Avezum, M.D., Ph.D., Fernando Lanas, M.D., Khalid Yusoff, M.B., B.S., Romaina Iqbal, Ph.D., Rafal Ilow, Ph.D., Noushin Mohammadifard, M.Sc., Sadi Gulec, M.D., Afzal Hussein Yusufali, M.D., Lanthe Kruger, Ph.D., Rita Yusuf, Ph.D., Jephat Chifamba, M.Phil., Conrad Kabali, Ph.D., Gilles Dagenais, M.D., Scott A.